Ophthalmic Drugs Market growth is projected to reach USD 58.3 Billion in 2024, at a 6.3% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.

Ophthalmic Drugs Market Size, growth and Analysis Report 2033

Ophthalmic Drugs Market

Ophthalmic Drugs Market Global Industry Analysis and Forecast (2024-2033) by Product (Prescription and OTC), Therapeutic Class (Anti-glaucoma drugs, Anti-VEGF agents, Anti-allergy drugs, Anti-inflammatory drugs, Anti-infective drugs, and Other therapeutic categories), Indication (Glaucoma, Dry eye, Infection/inflammation, Retinal disorder, Uveitis, Allergy, Myopia, FECD, Ptosis, Retinitis pigmentosa, and Other indications), Route of Administration (Topical, Local ocular (intravitreal), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region

Buyer Information

Order Summary

Report	Ophthalmic Drugs Market
Selected License	Single ID:IMR2080